$PZRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHASERX, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHASERX, INC.. Get notifications about new insider transactions in PHASERX, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2017 | PZRX | PHASERX, INC. | BRANDT GORDON | Chief Medical Offic ... | Option Exercise | A | 0.95 | 55,000 | 52,250 | 55,000 | |
May 30 2017 | PZRX | PHASERX, INC. | Phillips Peggy V | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
May 30 2017 | PZRX | PHASERX, INC. | JOHNSON PAUL H | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
May 30 2017 | PZRX | PHASERX, INC. | Schmidt John A Jr | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
May 30 2017 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
May 30 2017 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
May 30 2017 | PZRX | PHASERX, INC. | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
Jan 03 2017 | PZRX | PHASERX, INC. | BRANDT GORDON | Chief Medical Offic ... | Option Exercise | A | 1.45 | 20,000 | 29,000 | 20,000 | |
Jan 03 2017 | PZRX | PHASERX, INC. | OVERELL ROBERT W | President and CEO | Option Exercise | A | 1.45 | 100,000 | 145,000 | 100,000 | |
Jan 03 2017 | PZRX | PHASERX, INC. | Houston Michael | Chief Scientific Of ... | Option Exercise | A | 1.45 | 35,000 | 50,750 | 35,000 | |
Jan 03 2017 | PZRX | PHASERX, INC. | Tsui Shing-Yin | Senior VP, Finance, ... | Option Exercise | A | 1.45 | 20,000 | 29,000 | 20,000 | |
Aug 23 2016 | PZRX | PHASERX, INC. | BRANDT GORDON | Chief Medical Offic ... | Option Exercise | A | 3.16 | 125,000 | 395,000 | 125,000 | |
Aug 23 2016 | PZRX | PHASERX, INC. | Phillips Peggy V | Director | Option Exercise | A | 3.16 | 28,203 | 89,121 | 28,203 | |
Jul 06 2016 | PZRX | PHASERX, INC. | Tsui Shing-Yin | Senior VP, Finance, ... | Option Exercise | A | 4.29 | 50,000 | 214,500 | 50,000 | |
Jun 03 2016 | PZRX | PHASERX, INC. | Tsui Shing-Yin | VP, Finance, Secret ... | Option Exercise | A | 5.08 | 16,919 | 85,949 | 16,919 | |
Jun 03 2016 | PZRX | PHASERX, INC. | OVERELL ROBERT W | President & CEO | Option Exercise | A | 5.08 | 196,311 | 997,260 | 196,311 | |
Jun 03 2016 | PZRX | PHASERX, INC. | Houston Michael | Chief Scientific Of ... | Option Exercise | A | 5.08 | 52,267 | 265,516 | 52,267 | |
Jun 03 2016 | PZRX | PHASERX, INC. | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 5.08 | 13,631 | 69,245 | 13,631 | |
Jun 03 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 5.08 | 28,203 | 143,271 | 28,203 | |
Jun 03 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Option Exercise | A | 5.08 | 28,203 | 143,271 | 28,203 | |
Jun 03 2016 | PZRX | PHASERX, INC. | Schmidt John A Jr | Director | Option Exercise | A | 5.08 | 22,374 | 113,660 | 22,374 | |
Jun 03 2016 | PZRX | PHASERX, INC. | JOHNSON PAUL H | Director | Option Exercise | A | 5.08 | 28,203 | 143,271 | 28,203 | |
Jun 02 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 5.08 | 31,023 | 157,597 | 31,023 | |
May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 1.81 | 9,385 | 16,987 | 9,385 | |
May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Buy | P | 5.00 | 1,000,000 | 5,000,000 | 2,854,222 | 1.9 M to 2.9 M (+53.93 %) |
May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Sell | S | 0.01 | 195,156 | 1,952 | 1,854,222 | 2 M to 1.9 M (-9.52 %) |
May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Sell | S | 0.01 | 484,903 | 4,849 | 2,049,378 | 2.5 M to 2 M (-19.13 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 596,477 | 2,982,385 | 1,931,094 | 1.3 M to 1.9 M (+44.69 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 182,914 | 1,829 | 1,334,617 | 1.5 M to 1.3 M (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 73,615 | 736 | 1,517,531 | 1.6 M to 1.5 M (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 3,523 | 17,615 | 11,408 | 7.9 K to 11.4 K (+44.68 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 1,080 | 11 | 7,885 | 9 K to 7.9 K (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 435 | 4 | 8,965 | 9.4 K to 9 K (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 596,477 | 2,982,385 | 1,931,094 | 1.3 M to 1.9 M (+44.69 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 182,914 | 1,829 | 1,334,617 | 1.5 M to 1.3 M (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 73,615 | 736 | 1,517,531 | 1.6 M to 1.5 M (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 3,523 | 17,615 | 11,408 | 7.9 K to 11.4 K (+44.68 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 1,080 | 11 | 7,885 | 9 K to 7.9 K (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 435 | 4 | 8,965 | 9.4 K to 9 K (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | OVERELL ROBERT W | President & CEO | Option Exercise | A | 1.81 | 85,225 | 154,257 | 85,225 | |
May 24 2016 | PZRX | PHASERX, INC. | Houston Michael | Chief Scientific Of ... | Option Exercise | A | 1.81 | 52,432 | 94,902 | 52,432 | |
May 24 2016 | PZRX | PHASERX, INC. | Schmidt John A Jr | Director | Option Exercise | A | 1.81 | 5,631 | 10,192 | 5,631 | |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Buy | P | 5.00 | 3,796 | 18,980 | 35,552 | 31.8 K to 35.6 K (+11.95 %) |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Sell | S | 0.01 | 12,336 | 123 | 31,756 | 44.1 K to 31.8 K (-27.98 %) |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Sell | S | 0.01 | 4,965 | 50 | 44,092 | 49.1 K to 44.1 K (-10.12 %) |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Buy | P | 5.00 | 96,204 | 481,020 | 900,970 | 804.8 K to 901 K (+11.95 %) |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Sell | S | 0.01 | 312,647 | 3,126 | 804,766 | 1.1 M to 804.8 K (-27.98 %) |
May 23 2016 | PZRX | PHASERX, INC. | Ulevitch Richard J | Director | Sell | S | 0.01 | 125,829 | 1,258 | 1,117,413 | 1.2 M to 1.1 M (-10.12 %) |
Page: 1